Medtronic Rapid-Exchange Exit Contributes To 28% Decline In Vascular Sales
This article was originally published in The Gray Sheet
Executive Summary
A prolonged absence from the U.S. rapid-exchange delivery segment continues to encroach on Medtronic's once high-growth vascular intervention business unit